The 2016 World Health Organization (WHO) classification subdivides GBM into isocitrate dehydrogenase (IDH) mutant and IDH wild-type (wt), based on the mutational status of IDH1/IDH2 genes [4]. Here, IDH2 is linked to glioblastoma.